U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO Profiles

Items: 1 to 20 of 243

1.
The prognosis in spindle‐cell sarcoma depends on the expression of cyclin‐dependent kinase inhibitor p27Kip1 and cyclin E
Yoshinari Goto, Shigeto Kawauchi, Koichiro Lhara, Kenzo Ikemoto, Ritsuko Ohi, Shinya Kawai, Kohsuke Sasaki
Cancer Sci. 2003 May; 94(5): 412–417. Published online 2005 Aug 19. doi: 10.1111/j.1349-7006.2003.tb01456.x
PMCID:
PMC11160309
AbstractArticlePDF–401K
2.
PPM1D activity promotes the replication stress caused by cyclin E1 overexpression
Andra S. Martinikova, Miroslav Stoyanov, Anna Oravetzova, Yannick P. Kok, Shibo Yu, Jana Dobrovolna, Pavel Janscak, Marcel van Vugt, Libor Macurek
Mol Oncol. 2024 Jan; 18(1): 6–20. Published online 2023 Oct 16. doi: 10.1002/1878-0261.13433
PMCID:
PMC10766204
AbstractArticlePDF–1.8M
3.
LncRNA EILA promotes CDK4/6 inhibitor resistance in breast cancer by stabilizing cyclin E1 protein
Zijie Cai, Qianfeng Shi, Yudong Li, Liang Jin, Shunying Li, Lok Lam Wong, Jingru Wang, Xiaoting Jiang, Mengdi Zhu, Jinna Lin, Qi Wang, Wang Yang, Yujie Liu, Jun Zhang, Chang Gong, Herui Yao, Yandan Yao, Qiang Liu
Sci Adv. 2023 Oct 6; 9(40): eadi3821. Published online 2023 Oct 6. doi: 10.1126/sciadv.adi3821
PMCID:
PMC10558131
AbstractArticlePDF–2.9M
4.
Long noncoding RNA LINC02568 sequesters microRNA-874-3p to facilitate malignancy in breast cancer cells via cyclin E1 overexpression
YI DONG, LIANBO ZHANG, XIN GUAN, TAO LIU, LIMIN ZHOU
Oncol Res. 2021; 29(4): 291–303. Published online 2022 Aug 31. doi: 10.32604/or.2022.025172
PMCID:
PMC10208022
AbstractArticlePDF–13M
5.
N6-methyladenosine reader YTHDF2 promotes multiple myeloma cell proliferation through EGR1/p21cip1/waf1/CDK2-Cyclin E1 axis-mediated cell cycle transition
Rui Liu, Jiyu Miao, Yachun Jia, Guangyao Kong, Fei Hong, Fangmei Li, Meng Zhai, Ru Zhang, Jiaxi Liu, Xuezhu Xu, Ting Wang, Hui Liu, Jinsong Hu, Yun Yang, Aili He
Oncogene. 2023; 42(20): 1607–1619. Published online 2023 Apr 3. doi: 10.1038/s41388-023-02675-w
PMCID:
PMC10181929
AbstractArticlePDF–6.7M
6.
Systemwide disassembly and assembly of SCF ubiquitin ligase complexes
Kheewoong Baek, Daniel C. Scott, Lukas T. Henneberg, Moeko T. King, Matthias Mann, Brenda A. Schulman
Cell. 2023 Apr 27; 186(9): 1895–1911.e21. doi: 10.1016/j.cell.2023.02.035
Correction in:
Cell. 2023 May 25; 186(11): 2492.
PMCID:
PMC10156175
AbstractArticle
7.
Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity
Martin Golkowski, Andrea Lius, Tanmay Sapre, Ho-Tak Lau, Taylor Moreno, Dustin J. Maly, Shao-En Ong
Mol Cell. Author manuscript; available in PMC 2023 Apr 4.
Published in final edited form as: Mol Cell. 2023 Mar 2; 83(5): 803–818.e8. Published online 2023 Feb 2. doi: 10.1016/j.molcel.2023.01.015
PMCID:
PMC10072906
AbstractArticlePDF–4.2M
8.
CCNE1 is a predictive and immunotherapeutic indicator in various cancers including UCEC: a pan-cancer analysis
Xingyu Zheng, Lingli Chen, Wenlu Liu, Shuangshuang Zhao, Ye Yan, Jianzhen Zhao, Wenyan Tian, Yingmei Wang
Hereditas. 2023; 160: 13. Published online 2023 Mar 24. doi: 10.1186/s41065-023-00273-0
PMCID:
PMC10037856
AbstractArticlePDF–17M
9.
SCFFBXW7 regulates G2‐M progression through control of CCNL1 ubiquitination
Siobhan O'Brien, Susan Kelso, Zachary Steinhart, Stephen Orlicky, Monika Mis, Yunhye Kim, Sichun Lin, Frank Sicheri, Stephane Angers
EMBO Rep. 2022 Dec; 23(12): e55044. Published online 2022 Oct 24. doi: 10.15252/embr.202255044
PMCID:
PMC9724663
AbstractArticlePDF–3.3M
10.
Extracellular Polysaccharide from Rhizopus nigricans Inhibits Hepatocellular Carcinoma via miR-494-3p/TRIM36 Axis and Cyclin E Ubiquitination
Haixiong Yan, XiaoQian Ma, Ze Mi, Zhenhu He, Pengfei Rong
J Clin Transl Hepatol. 2022 Aug 28; 10(4): 608–619. Published online 2022 Feb 21. doi: 10.14218/JCTH.2021.00301
PMCID:
PMC9396321
AbstractArticlePDF–9.6M
11.
A dual-activity topoisomerase complex regulates mRNA translation and turnover
Shuaikun Su, Yutong Xue, Alexei Sharov, Yongqing Zhang, Seung Kyu Lee, Jennifer L Martindale, Wen Li, Wai Lim Ku, Keji Zhao, Supriyo De, Weiping Shen, Payel Sen, Myriam Gorospe, Dongyi Xu, Weidong Wang
Nucleic Acids Res. 2022 Jul 8; 50(12): 7013–7033. Published online 2022 Jun 24. doi: 10.1093/nar/gkac538
PMCID:
PMC9262614
AbstractArticlePDF–3.6M
12.
Clinical characteristics and outcomes of phase I cancer patients with CCNE1 amplification: MD Anderson experiences
Shuyang Yao, Funda Meric-Bernstam, David Hong, Filip Janku, Aung Naing, Sarina Anne Piha-Paul, Apostolia Maria Tsimberidou, Daniel Karp, Vivek Subbiah, Timothy Anthony Yap, Jordi Rodon Ahnert, Shubham Pant, Ecaterina E Ileana Dumbrava, Chetna Wathoo, Erick Campbell, Lihou Yu, Yuko Yamamura, Siqing Fu
Sci Rep. 2022; 12: 8701. Published online 2022 May 24. doi: 10.1038/s41598-022-12669-5
PMCID:
PMC9130298
AbstractArticlePDF–1.2M
13.
OpenCell: proteome-scale endogenous tagging enables the cartography of human cellular organization
Nathan H. Cho, Keith C. Cheveralls, Andreas-David Brunner, Kibeom Kim, André C. Michaelis, Preethi Raghavan, Hirofumi Kobayashi, Laura Savy, Jason Y. Li, Hera Canaj, James Y.S. Kim, Edna M. Stewart, Christian Gnann, Frank McCarthy, Joana P. Cabrera, Rachel M. Brunetti, Bryant B. Chhun, Greg Dingle, Marco Y. Hein, Bo Huang, Shalin B. Mehta, Jonathan S. Weissman, Rafael Gómez-Sjöberg, Daniel N. Itzhak, Loic A. Royer, Matthias Mann, Manuel D. Leonetti
Science. Author manuscript; available in PMC 2022 Sep 11.
Published in final edited form as: Science. 2022 Mar 11; 375(6585): eabi6983. Published online 2022 Mar 11. doi: 10.1126/science.abi6983
PMCID:
PMC9119736
AbstractArticlePDF–3.3M
14.
CCNE1 amplification is synthetic lethal with PKMYT1 kinase inhibition
David Gallo, Jordan T. F. Young, Jimmy Fourtounis, Giovanni Martino, Alejandro Álvarez-Quilón, Cynthia Bernier, Nicole M. Duffy, Robert Papp, Anne Roulston, Rino Stocco, Janek Szychowski, Artur Veloso, Hunain Alam, Prasamit S. Baruah, Alexanne Bonneau Fortin, Julian Bowlan, Natasha Chaudhary, Jessica Desjardins, Evelyne Dietrich, Sara Fournier, Chloe Fugère-Desjardins, Theo Goullet de Rugy, Marie-Eve Leclaire, Bingcan Liu, Vivek Bhaskaran, Yael Mamane, Henrique Melo, Olivier Nicolas, Akul Singhania, Rachel K. Szilard, Ján Tkáč, Shou Yun Yin, Stephen J. Morris, Michael Zinda, C. Gary Marshall, Daniel Durocher
Nature. 2022; 604(7907): 749–756. Published online 2022 Apr 20. doi: 10.1038/s41586-022-04638-9
PMCID:
PMC9046089
AbstractArticlePDF–15M
15.
A protein interaction landscape of breast cancer
Minkyu Kim, Jisoo Park, Mehdi Bouhaddou, Kyumin Kim, Ajda Rojc, Maya Modak, Margaret Soucheray, Michael J. McGregor, Patrick O’Leary, Denise Wolf, Erica Stevenson, Tzeh Keong Foo, Dominique Mitchell, Kari A. Herrington, Denise P. Muñoz, Beril Tutuncuoglu, Kuei-Ho Chen, Fan Zheng, Jason F. Kreisberg, Morgan E. Diolaiti, John D. Gordan, Jean-Philippe Coppé, Danielle L. Swaney, Bing Xia, Laura van ’t Veer, Alan Ashworth, Trey Ideker, Nevan Krogan
Science. Author manuscript; available in PMC 2022 Apr 26.
Published in final edited form as: Science. 2021 Oct; 374(6563): eabf3066. Published online 2021 Oct 1. doi: 10.1126/science.abf3066
PMCID:
PMC9040556
AbstractArticlePDF–2.2M
16.
Role of Genetic Variations in CDK2, CCNE1 and p27KIP1 in Prostate Cancer
MÁRK HÍVEŠ, JANA JUREČEKOVÁ, JÁN KLIMENT, MARIÁN GRENDÁR, PETER KAPLÁN, RÓBERT DUŠENKA, DANIEL EVIN, MARTA VILČKOVÁ, KLAUDIA HÍVEŠ HOLEČKOVÁ, MONIKA KMEŤOVÁ SIVOŇOVÁ
Cancer Genomics Proteomics. 2022 May-Jun; 19(3): 362–371. Published online 2022 May 3. doi: 10.21873/cgp.20326
PMCID:
PMC9016479
AbstractArticlePDF–1.0M
17.
CRL4AMBRA1 is a master regulator of D-type cyclins
Daniele Simoneschi, Gergely Rona, Nan Zhou, Yeon-Tae Jeong, Shaowen Jiang, Giacomo Milletti, Arnaldo A. Arbini, Alfie O’Sullivan, Andrew A. Wang, Sorasicha Nithikasem, Sarah Keegan, Yik Siu, Valentina Cianfanelli, Emiliano Maiani, Francesca Nazio, Francesco Cecconi, Francesco Boccalatte, David Fenyö, Drew R. Jones, Luca Busino, Michele Pagano
Nature. Author manuscript; available in PMC 2022 Apr 14.
Published in final edited form as: Nature. 2021 Apr; 592(7856): 789–793. Published online 2021 Apr 14. doi: 10.1038/s41586-021-03445-y
PMCID:
PMC8875297
AbstractArticlePDF–6.0M
18.
Two diphosphorylated degrons control c-Myc degradation by the Fbw7 tumor suppressor
Markus Welcker, Baiyun Wang, Domniţa-Valeria Rusnac, Yasser Hussaini, Jherek Swanger, Ning Zheng, Bruce E. Clurman
Sci Adv. 2022 Jan; 8(4): eabl7872. Published online 2022 Jan 28. doi: 10.1126/sciadv.abl7872
PMCID:
PMC8797792
AbstractArticlePDF–1.9M
19.
CDK1/FBXW7 facilitates degradation and ubiquitination of MLST8 to inhibit progression of renal cell carcinoma
Encheng Zhang, Siteng Chen, Heting Tang, Cheng Fei, Zhihao Yuan, Xingyu Mu, Yan Qin, Haixia Liu, Yu Fan, Mingyue Tan, Xiang Wang
Cancer Sci. 2022 Jan; 113(1): 91–108. Published online 2021 Nov 16. doi: 10.1111/cas.15188
PMCID:
PMC8748215
AbstractArticlePDF–3.5M
20.
CCNE1 and E2F1 Partially Suppress G1 Phase Arrest Caused by Spliceostatin A Treatment
Kei Kikuchi, Daisuke Kaida
Int J Mol Sci. 2021 Nov; 22(21): 11623. Published online 2021 Oct 27. doi: 10.3390/ijms222111623
PMCID:
PMC8584075
AbstractArticlePDF–3.4M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

You are here: NCBI > Literature > PubMed Central (PMC)
Support Center